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Mycobacterium tuberculosis and M. bovis infect animals and humans. Their epidemiologies in developed and
developing countries differ, owing to differences in the implementation of preventive measures (World Health
Organization, 1999). Identification and differentiation of these closely related mycobacterial species would help to
determine the source, reservoirs of infection, and disease burden due to diverse mycobacterial pathogens. The utility
of the hupB gene (Rv2986c inM. tuberculosis, orMb3010c inM. bovis) to differentiateM. tuberculosis andM. bovis was
evaluated by a PCR-restriction fragment length polymorphism (RFLP) assay with 56 characterized bovine isolates
(S. Prabhakar et al., J. Clin. Microbiol. 42:2724–2732, 2004). The degree of concordance between the PCR-RFLP
assay and the microbiological characterization was 99.0% (P< 0.001). A nested PCR (N-PCR) assay was developed,
replacing the PCR-RFLP assay for direct detection of M. tuberculosis and M. bovis in bovine samples. The N-PCR
products of M. tuberculosis and M. bovis corresponded to 116 and 89 bp, respectively. The detection limit of
mycobacterial DNA by N-PCR was 50 fg, equivalent to five tubercle bacilli. M. tuberculosis and/or M. bovis was
detected in 55.5% (105/189) of the samples by N-PCR, compared to 9.4% (18/189) by culture. The sensitivities of
N-PCR and culture were 97.3 and 29.7, respectively, and their specificities were 22.2 and 77.7%, respectively. The
percentages of animals or samples identified as infected with M. tuberculosis or M. bovis by N-PCR and culture
reflected the clinical categorizations of the cattle (P of <0.05 to <0.01). Mixed infection by N-PCR was detected in
22 animals, whereas by culture mixed infection was detected in 1 animal.
Mycobacterium bovis, the causative agent of bovine tubercu-
losis, has no known geographical boundaries. M. bovis infec-
tion occurs in diverse groups of animals, which include farm
animals of economic importance, wildlife, and humans (1, 16,
17, 31). Despite these ominous features of M. bovis, to date
there have been only projected global estimates of the disease
burden. There has been no international effort to determine
the actual disease burden, owing to the nonavailability of a
reliable user-friendly technology for early detection of M. bovis
in clinical samples. Bovine tuberculosis has been on the in-
crease in developed countries and continues to occur in devel-
oping countries (6, 14, 16). In Africa, approximately 85% of
cattle and 82% of the human population live in areas where the
disease is prevalent (6, 26). There are limited reports from
India (24, 27, 38, 40) and from underdeveloped countries (6,
16) relating to the prevalence of and infection with M. bovis in
cattle. Detection of M. bovis in bovine samples has become
necessary, as infected animals are potentially capable of infect-
ing humans (zoonotic tuberculosis) (6). Besides M. bovis, trans-
mission of M. tuberculosis from infected humans to animals and
back has been reported (reverse zoonosis) (10, 12, 41). Hence,
M. bovis and M. tuberculosis pose a potential health hazard to
both animals and humans (1, 15, 43).
The identification of the closely related members of the Myco-
bacterium tuberculosis complex (MTC) has remained a chal-
lenging task in diagnostic laboratories (7, 30, 44). MTC includes a
variety of closely related mycobacteria, namely, M. tuberculosis,
M. bovis, M. canetti, M. africanum, and M. microti. A panel of
classical tests based on microbiological features such as growth
rate and phenotypic and biochemical characteristics has con-
ventionally been utilized to distinguish members of MTC (30).
However, these tests are slow, cumbersome, unreliable, and
time-consuming. The high degree of variability among these
tests warrants the development of molecular biological tools
for identification of MTC members. In this regard, multiple
gene targets have been used to date to detect and differentiate
genetically identical species, such as M. tuberculosis and
M. bovis. The gene targets include pncA (2, 29, 36), gyrB (5),
oxyR (42), and katG (19). Huard et al. (21) and Richter et al.
(33) have targeted multiple loci and genes to differentiate
M. tuberculosis from M. bovis. However, to date no single ac-
cepted protocol(s) that can unambiguously differentiate all
members of the MTC is available. Identification of the etio-
logical agent belonging to MTC is important for determination
of the origin and reservoirs of infection and also for imple-
mentation of appropriate public health measures.
Our laboratory earlier described a PCR-restriction fragment
length polymorphism (RFLP) method utilizing the hupB gene,
* Corresponding author. Mailing address: Department of Biotechnol-
ogy, All India Institute of Medical Sciences, New Delhi 110029, India.
Phone: 91-11-26594994. Fax: 91-11-26852286. E-mail: hk_prasad
@hotmail.com.
† Present address: Section of Experimental Haematology/Oncology,
Department of Paediatric Haematology/Oncology, Medical School
Hanover, Carl Neuberg Strasse 1, D-30625 Hanover, Germany.
‡ A.M. and A.S. contributed equally to the manuscript.
5670
encoding a histone-like protein of M. tuberculosis, as a target
for detection and identification of M. tuberculosis and M. bovis
from other members of the MTC and nontuberculous myco-
bacterial and nonmycobacterial species (32). The study re-
vealed a 27-bp difference in the C-terminal parts of the hupB
genes of M. tuberculosis and M. bovis. The present study de-
scribes the reliability of the PCR-RFLP assay in the identifi-
cation of mycobacterial isolates derived from cattle and the
utility of the hupB gene-based nested PCR assay (N-PCR) for
direct detection of M. tuberculosis and/or M. bovis in bovine
samples.
MATERIALS AND METHODS
Study design. Samples (n  753) collected from 144 heads of cattle housed in
military farms under the jurisdiction of the Central Military Veterinary Labora-
tory (CMVL), Meerut, India, were used in the study. As a first step in the study,
56 randomly selected isolates derived from 544 samples of 80 animals were
examined for comparison of PCR-RFLP assay-based identification of M. tuber-
culosis and M. bovis, as described by Prabhakar et al. (32), with conventionally
identified and speciated mycobacteria. In the second part of the study, 189
samples obtained from 64 animals were screened by N-PCR for direct detection
of M. tuberculosis and M. bovis. N-PCR results have been correlated with stan-
dard techniques of identification and speciation of mycobacteria.
Animals. Clinical examination of the cattle was carried out at the Central
Military Veterinary Laboratory, Meerut. The clinical signs utilized were symp-
toms of lymphadenopathies, loss of body weight and/or production loss, inter-
mittent pyrexia, udder infection, and dry cough. A single intradermal tuberculin
test was carried out. One hundred microliters of bovine tuberculin (2,000 U/an-
imal), obtained from the Indian Veterinary Research Institute, Izatnagar, India
(1 mg protein/ml), was injected into the skin of the cervical area. Seventy-two
hours later, the injected site was examined, and the extent of induration was
measured. With an induration of 5 mm or more, the animal was considered to be
a reactor. Based on their in vivo tuberculin reactivities and clinical criteria, the
cattle were divided into five groups: group A, tuberculin positive with signs of
tuberculosis; group B, tuberculin positive and apparently healthy; group C,
tuberculin negative with signs of tuberculosis; group D, tuberculin negative and
apparently healthy; and group E, ailing from gastroenteritis and pyrexia of
unknown origin and clinically considered to be infected with nonmycobacterial
infection. C SC tuberculin testing was not done with group E. Seven samples were
collected from each animal, namely, fine needle aspirate (FNA) from the pres-
capular lymph node (PSLN), citrated blood, milk, pharyngeal swab, urine, rectal
pinch, and fecal sample. All samples were divided into two aliquots. The ali-
quoted samples were transported within 48 h of collection on wet ice to the
laboratories of H. K. Prasad and V. M. Katoch.
Identification of mycobacteria isolated from bovine samples. All samples were
processed for isolation and cultivation of mycobacteria from bovine samples in
the laboratory of V. M. Katoch by using the standard modified Petroff method.
Lowenstein-Jensen media with or without pyruvate was used for primary isola-
tion. Species level identification of isolates was done by standard biochemical
tests (niacin production, nitrate reduction, catalase and aryl sulfatase activity,
Tween hydrolysis, thiopen-2-carboxylic acid hydrazide sensitivity, etc.) as recom-
mended by the Centers for Disease Control and Prevention (CDC), Atlanta, Ga.,
with appropriate controls (45).
Processing of samples for isolation of template DNA for PCR. After initial
screening of the seven samples by culture, PSLN, citrated blood, and milk
samples were found to be suitable for isolation of M. tuberculosis and M. bovis.
These samples were processed for target DNA isolation in the laboratory of
H. K. Prasad by using the method as described by Chakravorty and Tyagi (3).
The specific details for each sample are as follows.
(i) The FNA of the PSLN was mixed with 1 ml of sterile water and centrifuged
at 12,000  g for 15 min. The pellet was resuspended in inhibitory removing
solution (IRS), pH 7.4, consisting of 25 M guanidinium isothiocyanate, 0.025 M
EDTA, 0.05 M Tris, 0.5% sarcosyl, and 0.186 M -mercaptoethanol (3), and
centrifuged. The pellet was washed in sterile water, suspended in 100 l of lysis
buffer (10% Chelex-100 suspension, 0.3% Tween 20, and 0.03% Triton X-100),
heated in a dry bath at 90°C for 40 min, and centrifuged at 10,000  g for 10 min.
The supernatant was used as target DNA.
(ii) Citrated blood was vortexed with ice-cold red blood cell (RBC) lysis buffer
(0.83% NH4Cl, 0.1% KHCO3, 0.5 M EDTA, pH 8.0) and incubated for 10 min.
The lysed RBC was separated by centrifugation at 12,000  g for 20 min. The
supernatant was discarded. The pellet was resuspended in RBC lysis buffer,
incubated, and centrifuged as described above. The pellet was resuspended in
IRS and processed as mentioned for PSLN.
(iii) Milk samples were centrifuged at 12,000  g for 20 min. A sterile cotton
swab was used to remove the fat layer, and the supernatant was discarded. The
pellet was resuspended in IRS and processed as mentioned for PSLN.
DNA extraction from bovine mycobacterial isolates. A loop full of isolate was
taken from the Lowenstein-Jensen slant and transferred to the 1.5-ml tube with
200 l of 0.1% Triton X-100. The resuspended bacteria was heated in a dry bath
at 90°C for 40 min and centrifuged at 10,000 g for 10 min. The supernatant was
used as target DNA.
PCR-RFLP for hupB gene. The PCR-RFLP assay for the hupB gene (All India
Institute of Medical Sciences, international patent application no. PCT/IN03/
00302, 1 July 2004, L. S. Davar and Co., Calcutta, India) was performed as
described earlier (32). Briefly, the primers N (5-GAGGGTTGGGATGAACAA
AGCAG-3) and S (5-TATCCGTGTGTCTTGACCTATTTG-3) were used to
amplify the hupB gene (N-S PCR) (Fig. 1A) from the DNA extracted from
various isolates. The amplified sequences were digested by the HpaII restriction
enzyme. The products were analyzed on a 10% nondenaturing polyacrylamide
gel. The gel was stained with ethidium bromide, and DNA fragments were
visualized under UV light.
N-PCR for C-terminal portion of hupB DNA target. The N-PCR for the
C-terminal portion of the hupB gene (international patent application no. PCT/
IN03/00302) was carried out using 4 l of the amplified product of the N-S PCR
as the template and primer pair F (5-CCAAGAAGGCGACAAAGG-3) and R
(5-GACAGCTTTCTTGGCGGG-3) (Fig. 1A). Each reaction (40 l) con-
tained 1.25 mM MgCl2, 200 M deoxynucleoside triphosphates, 0.5 M of F and
R primers, 10 mM Tris-HCl (pH 8.8), 50 mM KCl, 0.08% Nonidet P-40, and
1.0 U of Taq DNA polymerase (MBI Fermentas). The reaction mixture was
subjected to an initial denaturation at 94°C for 10 min and 35 cycles each of 1.0
min at 94°C and annealing and extension at 59°C for 30 s, followed by a final
extension at 72°C for 7.0 min. The products were analyzed on a 10% nondena-
turing polyacrylamide gel and stained with ethidium bromide. The expected sizes
of the amplicons for M. tuberculosis and M. bovis were 116 and 89 bp, respec-
tively.
Sensitivities of N-S and N-PCR assays. The sensitivities of the N-S and N-PCR
assays were deciphered by using different concentrations of M. tuberculosis DNA
(tuberculosis [TB] research material; NIH) ranging from 10 ng (106 bacilli) to
10 fg (1 bacillus). The expected sizes of the amplicons for the N-S and N-PCR
assays were 645 and 116 bp, respectively.
Statistical analysis. The results of the PCR assay were compared with those
of culture by using agreement and kappa tests. The correlation of detection of
M. tuberculosis and/or M. bovis in bovine samples with clinical categorization and
diagnosis of the cattle included in the study was assessed by a trend chi-square
test. The positivity of samples was also assessed by a chi-square test. All statistical
analysis was done using the statistical software STATA 7.0 (STATA Corpora-
tion, College Station, Texas).
RESULTS
Correlation of identification of M. tuberculosis and M. bovis
by PCR-RFLP assay and standard culture techniques. The
utility of the PCR-RFLP assay to differentiate and identify
M. tuberculosis and M. bovis (32) was independently confirmed
in the laboratory of V. M. Katoch (Table 1). Fifty-six isolates
derived from 544 samples identified by standard criteria were
used in the assay. Thirty-three isolates were identified as
M. bovis, 7 as M. tuberculosis, and 15 as nontuberculous myco-
bacteria. One isolate identified as M. bovis failed to be identi-
fied by the PCR-RFLP assay. The degree of correlation be-
tween the two techniques was determined to be 99.0% ( 
0.96 	 0.11; P 
 0.001).
Among the assortment of samples screened by culture,
PSLN, milk, and blood showed the highest isolation rates.
Hence, pharyngeal swab, rectal pinch, urine, and fecal samples
were not used subsequently.
N-PCR for detection and identification of M. tuberculosis and
M. bovis. In order to establish a routine PCR-based assay for
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detection and identification of M. tuberculosis and M. bovis in
clinical samples not requiring RFLP analysis, a nested PCR
assay was developed. The difference in the C-terminal parts of
the hupB genes of M. tuberculosis (Rv2986c) and M. bovis
(Mb3010c) was exploited. The ethidium bromide-stained am-
plified products of M. tuberculosis and M. bovis generated by
the N-PCR are depicted in Fig. 1B. The 116- and 89-bp prod-
ucts obtained for M. tuberculosis and M. bovis, respectively, are
indicated. Figure 1C shows the alignment of the N-PCR prod-
ucts of M. tuberculosis and M. bovis, indicating the 27-bp dif-
ference.
Sensitivity of the N-PCR assay. The limit of sensitivity of the
N-PCR assay to detect M. tuberculosis DNA was determined by
using various concentrations of DNA. The products of the N-S
PCR and N-PCR are shown in Fig. 2A and B, respectively. The
amplified N-S PCR product could be detected up to a 0.1-ng
DNA concentration, equivalent to 104 bacilli (Fig. 2A, lanes 2
FIG. 1. Nested PCR to amplify C-terminal part of hupB gene. (A) The positions of the primers in the hupB (Rv2986c in M. tuberculosis, or
Mb3010c in M. bovis) sequence that were used to obtain the nested PCR products are depicted. Primer pair N and S was specific for the hupB gene;
internal primer pair F and R was specific for the C-terminal part of the gene. The F and R primers were used to reamplify the amplified product
generated by the N and S primers (N-PCR). (B) The ethidium bromide-stained amplification products of M. tuberculosis and M. bovis generated
by using F and R primers were electrophoresed on nondenaturing 10% polyacrylamide gels. The 116- and 89-bp products obtained for
M. tuberculosis and M. bovis, respectively, are indicated. Lanes: 1, negative control; 2, M. tuberculosis (M. tuberculosis DNA from TB research
material; NIAID, NIH); 3, 100-bp molecular size marker; 4, M. bovis (AN5 strain; JALMA, Agra, India). (C) Sequences of F and R amplified PCR
products of M. tuberculosis (tb) (116 bp) and M. bovis (89 bp) were aligned using ClustalW software to depict the 27-bp deletion in M. bovis,
indicated by the arrow.
TABLE 1. Correlation of gold standard identification of mycobacterial
isolates derived from bovine samples with PCR-RFLP assay
Type of
mycobacterium
No. of isolates identified by:
Concordance
(%)Standard
criteriaa
PCR-RFLP
assayb
M. bovis 34 33 97.0
M. tuberculosis 7 7 100
Nontuberculous
mycobacteria
15 15 100
Total 56 55 99.0c
a Criteria as outlined by the CDC, Atlanta, Ga. (45).
b Analysis of amplified products of M. tuberculosis (645 bp) and M. bo-
vis (618 bp) by N and S primers digested with HpaII as described by Prabhakar
et al. (20). One M. bovis isolate was not amplified by the PCR assay.
c   0.96 	 0.11; P 
 0.001.
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to 5). However, in the case of N-PCR, the amplified product
could be visualized in the PCR mixture initiated with DNA
concentrations ranging from 10 ng to 50 fg, the latter of which
is equivalent to 5 tubercle bacilli (Fig. 2B, lanes 2 to 11). The
sensitivity of the N-PCR assay was determined to be 2,000
times more than that of the N-S PCR assay. The sensitivity of
the N-PCR for detection of M. bovis DNA was found to be
identical to the sensitivity of the N-PCR for detection of
M. tuberculosis DNA (data not shown).
N-PCR for direct detection ofM. tuberculosis and/orM. bovis in
bovine samples. DNA extracted from bovine samples, namely,
milk, blood, and FNA of PSLN, were used in an N-PCR assay.
The amplified products obtained with representative bovine
samples are shown in Fig. 3. Figure 3A depicts the N-S PCR
products for bovine samples. PCR product sizes of 618 and 645
bp specific for M. bovis and M. tuberculosis, respectively, are
seen in lanes 5 and 6, derived from milk and blood samples,
respectively (Fig. 3A) (32). Figure 3B depicts the N-PCR prod-
ucts for the bovine samples. The molecular sizes and extents of
migration of the N-PCR products generated in the samples
were compared with those of the positive controls, namely,
M. tuberculosis (TB research material; NIH) (Fig. 3B, lane 2)
and M. bovis (AN5; JALMA, Agra, India) (Fig. 3B, lane 3).
N-PCR products were seen for all samples except that in lane
7 (Fig. 3B). PCR products of milk samples loaded in lanes 4
and 5 (Fig. 3B) were identified to be M. bovis. Since the N-PCR
products derived from blood (lane 6) and lymph node aspirates
(lanes 8 and 9) matched with the N-PCR product of M. tuber-
culosis (lane 2), they were predicted to be M. tuberculosis.
Speciation of pathogenic mycobacteria in bovine samples.
Speciation of the pathogenic mycobacteria was done for 87.6%
(99/113) of the samples by N-PCR (Table 2). For six samples,
which were positive for the MTC, speciation could not be
established by N-PCR. Neither by N-PCR nor by standard
culture techniques was M. tuberculosis or M. bovis found to
predominate in the samples investigated. M. bovis was detected
in 40.7% of the samples and M. tuberculosis was detected in
37.1% of the samples by N-PCR (Table 2).
Mycobacteria were isolated and identified by standard cul-
ture techniques in 33 samples of the 189 examined. Ten sam-
ples (8.8%) were diagnosed as infected with M. tuberculosis
and eight (7.1%) with M. bovis (Table 2). In the remaining 15
samples, nontuberculous rapid-growing mycobacteria, such as
M. scrofulaceum, M. kansasii, M. flavescens, M. smegmatis,
M. fortuitum, M. gastri, M. phlei, M. vaccae, and M. chelonae,
were identified. Among the samples investigated, milk was
found to be predominantly positive for M. tuberculosis and/or
M. bovis by N-PCR (46/48 samples; P 
 0.001) and blood
predominantly positive by culture (7/30 samples).
Mixed infection with M. tuberculosis and M. bovis in bovine
samples. A limited number of samples scrutinized by the N-
PCR assay showed evidence of mixed infection by M. tubercu-
losis and M. bovis in individual animals. Precautions were
taken, keeping in mind the possibility of laboratory-introduced
contamination during processing of samples. Each sample was
processed individually within a biosafety cabinet (type III),
minimizing the possible introduction of contaminants from the
environment by aerosols or another infected sample. Further,
the PCR has always been carried out with appropriate controls,
which include positive controls for M. tuberculosis and M. bovis
and a negative control (Fig. 3C). The routine inclusion of a
negative control in the assay ruled out the occurrence of false-
FIG. 2. Sensitivity of N-PCR assay. (A) The ethidium bromide-stained amplification products of the target hupB gene of M. tuberculosis
generated using primers N and S were electrophoresed on nondenaturing 10% polyacrylamide gels. The 645-bp product is indicated. The
M. tuberculosis DNA used was obtained from TB research materials, NIAID, NIH. Lanes: 1, 100-bp molecular size marker; 2, 10 ng DNA (106
bacilli); 3, 1 ng DNA (105 bacilli); 4, 0.5 ng DNA (5 104 bacilli); 5, 0.1 ng DNA (104 bacilli); 6, 10 pg DNA (103 bacilli); 7, 1 pg DNA (100 bacilli);
8, 0.5 pg DNA (50 bacilli). (B) The ethidium bromide-stained amplification products of the C terminal of the hupB gene of M. tuberculosis
generated using F and R primers in N-PCR were electrophoresed on nondenaturing 10% polyacrylamide gels. N and S amplified PCR products
(4 l) were used as a template. Lanes: 1 to 8, same as described for panel A; 9, 0.25 pg DNA (25 bacilli); 10, 100 fg DNA (10 bacilli); 11, 50 fg
DNA (5 bacilli); 12, 10 fg DNA (1 bacillus); 13, negative control.
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positive PCR caused by contamination. Further, the organiza-
tional setup for the PCR assay was such that the sites for
processing of samples for DNA extraction, setting up of the
PCR, addition of extracted DNA, and screening of gels and
capturing of the images were in physically separated rooms. To
further rule out the possibility of false-negative results in the
study due to the presence of PCR inhibitors in DNA extracts
of samples, spiked controls were used. The generation of the
expected PCR product in the spiked controls showed the ab-
sence of sample-derived PCR inhibitors (data not shown).
FIG. 3. N-PCR for detecting and differentiating M. tuberculosis and M. bovis in samples of bovine origin. (A) The ethidium bromide-stained
amplification products of the hupB gene generated using primers N and S were electrophoresed on nondenaturing 10% polyacrylamide gels. The
645- and 618-bp products corresponding to M. tuberculosis and M. bovis, respectively, are indicated. Lanes: 1, 100-bp molecular size marker; 2,
M. tuberculosis positive control; 3, M. bovis positive control; 4, milk serial no. 103; 5, milk 104; 6, blood 123; 7, blood 127; 8, PSLN 90; 9, PSLN
95; 10, negative control. (B) The ethidium bromide-stained amplification products of the C terminal of the hupB gene of M. tuberculosis generated
using F and R primers in the N-PCR assay were electrophoresed on nondenaturing 10% polyacrylamide gels. N and S amplified PCR products
(4 l) were used as a template. Lanes 1 to 10 are the same as described for panel A. (C) N-PCR of bovine samples depicting mixed infection. Lanes:
1, 100-bp molecular size marker; 2, PSLN serial no. 104; 3, milk 119; 4, M. tuberculosis positive control; 5, M. bovis positive control; 6, dual positive
control; 7, negative control.
TABLE 2. Detection of pathogenic mycobacteria in cattle-derived samples
Sample type
(total no. of samples positive
by N-PCR and culture)
No. (%) of bovine samples positive for pathogenic mycobacteria byd:
N-PCR Culturea
M. tuberculosis M. bovis M. tuberculosisand M. bovisb Total Not done
c M. tuberculosis M. bovis Total
PSLN (35) 10 15 3 28 (80.0) 4 2 2 4 (11.4)
Blood (30) 12 12 1 25 (83.3) 1 5 2 7 (23.3)
Milk (48) 20 19 7 46 (95.8) 1 3 4 7 (14.2)
Total (113) 42 (37.1) 46 (40.7) 11 (9.7) 99 (87.6) 6 10 (8.8) 8 (7.1) 18 (15.7)
a Identification of cultivated mycobacterial isolates by standard tests (CDC, Atlanta, Ga.).
b M. tuberculosis and M. bovis detected in samples derived from a single animal/in an individual sample.
c Speciation could not be established by N-PCR but samples were positive for MTC.
d M. tuberculosis versus M. bovis results were not significant. Results with milk versus PSLN versus blood had a P value of 
0.001.
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Representative N-PCR products from samples, namely, milk
and lymph node aspirates, exhibiting mixed infection are de-
picted in Fig. 3C (lanes 2 and 3). In each of the samples,
N-PCR products corresponding in molecular weight to that
of the positive control, namely, M. tuberculosis (lane 4) or
M. bovis (lane 5), or the dual-positive control (lane 6) were
prominent and distinct.
Mixed infection was detected in 11 samples derived from
nine animals (Table 2). In some instances, samples acquired
from a single animal showed dual infection with M. tuberculosis
and M. bovis, i.e., while one sample was positive for M. bovis,
in the second sample M. tuberculosis was detected. These an-
imals were also grouped in the mixed-infection category. Thir-
teen animals were identified in this group. By culture, one
animal was shown to harbor both of the pathogens (mixed
infection) (Table 3, serial no. 100), i.e., M. tuberculosis was
isolated from the lymph node aspirate and M. bovis from milk.
No individual sample was established by culture to harbor both
M. tuberculosis and M. bovis, as was seen with samples exam-
ined by the N-PCR assay.
Comparative analysis of detection of M. tuberculosis and
M. bovis by N-PCR and the standard culture technique. Dif-
ferences in detection and identification of M. tuberculosis and
M. bovis in bovine samples by standard culture techniques and
the N-PCR technique were observed. The results of the N-
PCR and standard identification techniques correlated in 45%
of the samples (85/189). N-PCR-based identification matched
the results obtained by the standard identification techniques
in nine samples (Table 3, serial no. 92, 104, 105, 128, 129, 141,
147, 149, and 152). Seventy-six samples were negative by both
techniques. However, variation at the species level of identifi-
cation of mycobacteria present in the samples derived from
seven animals was seen (Table 3, serial no. 91, 94, 109, 111,
113, 134, and 140). Samples derived from one animal (Table 3,
serial no. 100) were negative by N-PCR.
Table 4 depicts the comparative analysis of the standard
culture technique with N-PCR for the detection of M. tuber-
culosis and M. bovis in cattle, based on tuberculin reactivity.
The sensitivities of N-PCR and culture were calculated to be
97.3 and 29.7%, respectively. The specificity of N-PCR was
lower (22.2%) than that of culture (77.7%).
For all categories of animals, i.e., A, B, C, and D, and their
samples, the sensitivities of detection of M. tuberculosis and/or
M. bovis were dissimilar by the two assays. However, the trends
of detection or isolation of M. tuberculosis and/or M. bovis from
various animals were similar when taking into consideration
the clinical categories of the animals examined (culture, P of

0.05; N-PCR, P of 
0.01). In group A, all animals (100%,
20/20) were positive by N-PCR, whereas 45% (9/20) were pos-
itive by culture. This trend of detection decreased in the re-
maining groups. For groups B, C, and D, the percentages of
positivity were determined to be 94, 90, and 66.6% by N-PCR
and 12.5, 44, and 22.2% by culture, respectively. Identical de-
tection patterns of M. tuberculosis and/or M. bovis were seen
when considering all samples, namely, PSLN, blood, and milk.
However, among the samples screened by the N-PCR assay,
PSLN paralleled and reflected best the various groups of cattle
studied (P 
 0.01). The highest percentage of positivity was
seen for group A (75%). Reductions in percent positivity were
seen for the remaining groups, namely, 53% for group B, 30%
for group C, and 33% for group D.
Seventy-five percent of the animals (6/8) included in group E
were positive for M. tuberculosis and/or M. bovis by N-PCR.
TABLE 3. Comparative analysis of detection of pathogenic mycobacteria in cattle-derived samples by N-PCR and by standard
identification tests
Sample
serial no.
Pathogenic mycobacterium(a) detected byd:
N-PCR Standard identificationa
PSLNb Blood Milk PSLN Blood Milk
92 —e M. tuberculosis M. tuberculosis — M. tuberculosis —
104 M. tuberculosis and M. bovisc M. bovis M. bovis — — M. bovis
105 — M. bovis M. tuberculosis — — M. tuberculosis
128 — — M. tuberculosis — — M. tuberculosis
129 ND M. tuberculosis M. bovis — M. tuberculosis —
141 M. bovis — — M. bovis — —
147 — — M. bovis — — M. bovis
149 — — M. bovis — — M. bovis
152 M. tuberculosis and M. bovis M. tuberculosis and M. bovis NA M. tuberculosis — NA
91 M. tuberculosis — M. tuberculosis — M. bovis —
94 M. tuberculosis M. tuberculosis M. tuberculosis M. bovis — —
109 — — M. tuberculosis — M. tuberculosis —
111 — — M. tuberculosis — M. tuberculosis —
113 — M. bovis M. bovis M. tuberculosis — —
134 — — M. bovis — M. bovis
140 M. bovis M. tuberculosis — — — M. tuberculosis
100 — — — M. tuberculosis — M. bovis
a Identification of cultivated mycobacterial isolates by standard tests (CDC, Atlanta, Ga.).
b FNA derived from periscapular lymph gland.
c M. tuberculosis and M. bovis detected in samples derived from a single animal/in an individual sample.
d ND, speciation not done. PCR product identified as derived from mycobacteria belonging to the MTC. NA, not available.
e —, no mycobacterial pathogen detected or isolated.
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However, by culture no mycobacteria, either pathogenic or
nonpathogenic, were isolated.
DISCUSSION
Handling of infected herds varies in accordance with local
laws in developed countries and economic compulsions and
religious norms in developing countries like India and some
East Asian countries where the cow is revered. Rigorous
containment and elimination of infected animals in developed
countries has contributed to reducing the prevalence of bovine
tuberculosis. However, despite the implementation of the test-
and-slaughter policy in Great Britain bovine tuberculosis spread
remains unchecked, indicating that there exist insidious mecha-
nisms that facilitate the spread of bovine tuberculosis (14). The
occurrence of bovine tuberculosis in wild animals and the
movement of infected cattle from areas where the disease is
endemic to regions relatively free of bovine tuberculosis have
been cited as possible reasons (8, 14, 47). The implications of
this in terms of habitual or organized or disorganized cattle
migrations in developing countries is significant to the spread
of M. bovis, M. tuberculosis, and other related and unrelated
pathogens.
Reliable diagnosis of bovine tuberculosis in live animals
remains a major problem among veterinarians. The tuberculin
test has been used commonly to identify infected animals.
Nevertheless, owing to problems of sensitivity and specificity,
the currently used intradermal tuberculin test has been highly
variable. Tuberculin reactivity has been known to be influ-
enced by a variety of intrinsic host-related factors (immuno-
logical) as well as extrinsic factors, such as the technique,
method, quality of the tuberculin used, etc. A negative tuber-
culin test does not rule out infection, especially in countries
where the disease is highly endemic, whereas a positive reac-
tion reflects a hypersensitivity reaction owing to previous ex-
posure to mycobacteria. The tuberculin test is limited to the
detection of infected animals, whereas from the viewpoint of
describing the origin, link, and reservoirs of infection, identi-
fication of mycobacterial species in bovines has its merits.
Traditionally, culture followed by a panel of biochemical
tests has been used for speciation of mycobacteria. This has
inherent disadvantages, as most mycobacteria of clinical im-
portance are slow growers and hence are difficult to isolate and
cultivate. The time required for primary isolation ranges from
4 to 6 weeks in the case of solid culture media and 10 to 15 days
by radiometric and other automated systems. Moreover, the
paucibacillary nature of clinical samples also accounts for the
low efficiency of isolation of pathogenic mycobacteria (11, 23,
39). In addition to difficulties in primary isolation of mycobac-
terial pathogens, particularly M. bovis, there have been reports
of difficulty in differentiating closely related mycobacterial spe-
cies (7, 30, 34, 44). Therefore, there is a need to develop
molecular biological tools like PCR-based assays for reliable,
early detection and speciation of mycobacteria in clinical sam-
ples and, as a consequence, for determination of the disease
burden caused by diverse pathogenic mycobacteria.
Some of the difficulties that determine the success of isola-
tion and detection of M. tuberculosis and/or M. bovis by culture
or PCR-based assays are common to both assays and others
are exclusive for each assay. Culture techniques depend on
viable bacteria and therefore reflect ongoing infection. In the
case of PCR, the test can be positive in the absence of viable
integral mycobacteria. The success level of culture can be de-
termined by (i) growth rates and the presence of associated
microorganisms which would hinder the prospect of isolation
of slow growers (several medium and fast growers, such as
M. scrofulaceum, M. kansasii, M. flavescens, M. smegmatis,
M. fortuitum, M. gastri, M. phlei, M. vaccae, and M. chelonae,
were isolated from bovine samples in this study); (ii) notwith-
standing prolonged incubation, the inability of potential iso-
lates to adapt to in vitro culture conditions, especially in situ-
ations where the number of bacilli are limiting, which could
result in false-negative results by culture; (iii) the variability in
the tedious process of identification, which has been reported
to be a problem; and (iv) the composition of the media used
for primary isolation, particularly of M. bovis, from clinical
isolates (17). Though PCR-based methods are useful for rapid
detection of target DNA in suspected clinical samples, the
efficacy of PCR assays can be influenced by the quality of target
DNA extracted from appropriate samples and the presence of
sample-derived PCR inhibitors. These problems have been
addressed by several workers (3, 4, 9). Their methods and
spiked controls have been adopted in the present study to
overcome these problems. Unlike culture, the PCR technique
does not distinguish between live and dead mycobacteria, a
feature that is of the utmost importance when screening for
viable mycobacteria in samples such as dairy products follow-
ing pasteurization.
The N-PCR assay described in the present study is based on
the hupB genes of M. bovis and M. tuberculosis. The specificity
of the hupB-based PCR assay to detect and identify M. bovis
and M. tuberculosis has been established by using a wide variety
of mycobacterial and nonmycobacterial microorganisms (32).
Further, the reliability of the assay was demonstrated by using
TABLE 4. Comparative analysis of N-PCR and culture by tuberculin reactivity status of the animals investigated
Assay Result
No. of animals with tuberculin
statusa Sensitivity
(%)
Specificity
(%)
Positive predictive
value (%)
Negative predictive
value (%)
R (n  37) NR (n  27)
N-PCR Positive 36 21 97.3 22.2 63.2 85.7
Negative 1 6
Culture Positive 11 6 29.7 77.7 64.7 44.7
Negative 26 21
a R, reactor (5-mm induration at 72 h); NR, nonreactor (
5-mm induration at 72 h).
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M. bovis and M. tuberculosis strains from different geographical
regions (32). The limit of detection by the N-PCR assay was
shown to be five bacilli, equivalent to 50 fg of DNA. Kidane et
al. (23) and Shah et al. (37) have reported the multiplex-PCR-
based detection and differentiation of M. tuberculosis and
M. bovis by use of clinical samples and mycobacterial isolates,
respectively. The sensitivities of the assays were limited to
detect 10 to 20 pg DNA of the tubercle bacilli. The sensitivity
of the N-PCR technique may lead to false positives based on
clinical criteria and in comparison to the culture techniques.
The reasons for this could be due to (i) the detection of
M. tuberculosis and M. bovis in clinical samples by the N-PCR
prior to the onset of clinical signs and symptoms of tuberculosis
and/or (ii) the presence of dead, noncultivatable bacilli in sam-
ples. The increased sensitivity of the N-PCR assay resulted in
a lower specificity than that for culture (Table 4). Hence, the
results of the N-PCR could potentially point to infection rather
than disease. However, the probability of false-positive results
being generated by the N-PCR technique is low because the
likelihood of an incorrect region or nonspecific DNA being
erroneously amplified twice is remote (46). Further, no corre-
lation between tuberculin reactivity status and the results of
culture and N-PCR was found among the animals examined.
We report the utility of the N-PCR assay for the direct
detection of M. tuberculosis and M. bovis in bovine samples as
an alternate method to the currently described spoligotyping
technique, which is yet another test to distinguish members of
the MTC (13, 20, 22, 35). The N-PCR assay not only permitted
distinguishing M. tuberculosis and/or M. bovis in bovine sam-
ples but also facilitated categorizing different types of infection
in cattle, that is, infection with either M. tuberculosis or
M. bovis or both. This feature of the N-PCR has a distinct
advantage over the spoligotyping technique, as mixed infec-
tions cannot be discerned by the latter. Mixed infection by
M. tuberculosis and M. bovis in human lymph node biopsy spec-
imens has also been reported (23). Besides mixed infection by
M. tuberculosis and M. bovis, several other mycobacteria, such
as members of Mycobacterium avium complex and M. fortui-
tum, have been reported to occur along with M. tuberculosis
infection (25). The detection of both pathogens in the cattle
investigated suggests a twin danger of infected cattle being a
source of mycobacterial pathogens capable of infecting animals
and humans. Contact between farm animals and humans
would naturally facilitate a bidirectional infection of mycobac-
terial pathogens.
The presence of M. tuberculosis in bovine samples is indic-
ative of reverse zoonosis, as has been reported for animals in
contact with humans (1, 10, 12). It has been documented that
animals can be infected by exposure to any individual shedding
the organism (1, 12). Sjogren and Hillerdal (41) cited several
examples of human-to-cattle transmission and stressed the po-
tential danger that patients with smear-positive pulmonary tu-
berculosis pose to animals. Grange and Yates (18) reported
that farm workers urinating in cowsheds might represent a
source of infection for animals. Animals infected with M. tu-
berculosis constitute a potential hazard of transmission of vir-
ulent tubercle bacilli back to humans (12). Therefore, there is
a compelling need to detect tuberculosis among cattle handlers
and farmers, as humans are the major reservoir of M. tubercu-
losis, unlike with M. bovis. Speciation of these pathogens would
help the formulation of public heath strategies to interrupt the
transmission chain not only intrinsically among cattle but also
between humans and cattle. This demands the implementation
of rigorous, strict policies regarding the detection of tubercu-
losis among animals and cattle handlers. Besides speciation of
mycobacteria isolated from cattle, molecular markers need to
be included to establish the unequivocal relationship between
strains isolated from humans and those isolated from cattle.
The identification of M. tuberculosis and M. bovis by the
N-PCR assay in bovine samples has helped to bring into focus
(i) the prevalence and the incidence of M. bovis and M. tuber-
culosis infections in bovines and (ii) the grave implications of
the high frequency of occurrence of potential human mycobac-
terial pathogens among cattle of economic importance. The
assay would prove especially useful in developing countries
with a high incidence of infected livestock (16). M. bovis has
been known to spread to humans from infected cattle (zoo-
notic tuberculosis) by aerosol or by consumption of contami-
nated dairy products (6, 28). The epidemiological impact of
M. bovis infection in humans has not been assessed. This assay
has been utilized for the detection of M. bovis infection in
extrapulmonary samples of human origin (N. P. Shah et al.,
submitted for publication). The presence and occurrence of
these twin pathogens in the environment have grave implica-
tions for the currently adopted strategies for prevention and
control of human tuberculosis. The occurrence of simulta-
neous infection of M. bovis and M. tuberculosis in an individual
sample reflects the concurrent infection that occurs due to the
prevalence and circulation of both of these pathogens in the
environment.
Therefore, the current N-PCR assay would be of immense
utility in redefining research priorities and public health strat-
egies for control and prevention of tuberculosis in farm ani-
mals as well as in humans, since the duo, M. tuberculosis and
M. bovis, is capable of infection and of causing both human and
bovine tuberculosis. Hence, there is a need to develop tech-
niques similar to the currently described N-PCR which would
provide evidence of the occurrence of tuberculosis in humans
and cattle by these common mycobacterial pathogens. This in
turn would provide a sound rationale for the generation of
hitherto-elusive antitubercular vaccines to protect susceptible
humans and animals alike.
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